Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

NCT01608243 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Stallergenes Greer